Espinoza Octavio bought LGND
February 27, 2024 · Form 4 insider transaction
Espinoza Octavio bought 7,208 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,208
Price
$0.00
Total value
N/A
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after28,631
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.